Bookmarks
Salford Lung Study
Population Size
Years
2012 - 2016
Associated BioSamples
None/not available
Geographic coverage
United Kingdom
England
...see more
Lead time
2-6 months
Summary
Documentation
SLS Asthma - Primary Effectiveness Analysis (PEA) - This population is defined as all ITT subjects (all randomised subjects who receive at least one prescription of study medication [e.g. FF/VI or Usual Care]) who have an ACT total score of < 20 at baseline (Day 0). This population will be based on the treatment to which the subject was randomised.
SLS COPD - Primary Effectiveness Analysis (PEA) - This population comprised all ITT subjects (all randomised subjects who received at least one prescription for study medication [e.g. FF/VI or usual care] who had at least one moderate/severe exacerbation in the year prior to Visit 2 (randomisation), as recorded on the eCRF.
Dataset type
Dataset sub-type
Keywords
Provenance
Purpose of dataset collection
Source of data extraction
Collection source setting
Image contrast
Biological sample availability
Details
Publishing frequency
Version
Modified
08/10/2024
Distribution release date
04/12/2016
Citation Requirements
Coverage
Start date
13/03/2012
End date
04/12/2016
Time lag
Geographic coverage
Minimum age range
Maximum age range
Accessibility
Language
Controlled vocabulary
Format
Data Access Request
Dataset pipeline status
Access rights
Time to dataset access
Access request cost
Access method category
Access service description
Data use limitation
Data Controller
Data Processor